Press "Enter" to skip to content

Recombinant Protein Market 2019: Comprehensive Analysis by Top Key Companies, Industry Growth, Size, Share, Market Insights, Sales Volume and Forecast to 2024

Recombinant

The “Recombinant Protein Market” research report 2019-2024 delivers comprehensive information and valuable insights about the Recombinant Protein industry. The information available in the Recombinant Protein market report is not only based on the facts but also on the case studies, which analysts have included to convey appropriate information to the clients in a well-versed manner. Recombinant Protein market report includes valuable information to assist new entrants, as well as established players, to understand the prevailing trends in the market.

Some Companies Are Covered in the Recombinant Protein Market:

  • Abcam PLC
  • Abnova Corporation
  • Eli Lilly and Company
  • Enzo Life Sciences Inc.
  • Eurogentec (Kaneka Corporation)
  • Merck KGaA
  • Novo Nordisk AS
  • ProSpec
  • Tany TechnoGene Ltd
  • ProSpec
  • Tany TechnoGene Ltd
  • F. Hoffmann
  • La Roche AG
  • Thermo Fisher Scientific Inc.

    Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/14099224

    Market Overview:

  • The growth of the recombinant protein market is attributed due to increased expenditure in R&D, the growing prevalence of chronic diseases, rising inclination toward biologics and biosimilars, and advanced recombinant products.
  • R&D is defined as the process of creating new products, processes, and technologies that can be used and marketed for mankind’s benefit in the future. New drugs serving unmet medical needs are one of the key value drivers of research-based pharmaceutical companies. The rate of growth in R&D funding, in 2015, and the location of that growth are both significant. Trends are showing a return to growth, with only minor caution, across most areas of R&D spending. The increase in R&D investment in Asia, particularly China, and the consecutive annual growth in R&D spending in North America indicates a period of stability, security, and healthy competition across industrial sectors. As per the 2016 Global R&D Funding Forecast, this year, sponsored by the Industrial Research Institute (IRI), Washington, DC, reveals that global R&D investments may increase by 3.5% in 2016, to a total of USD 1.948 trillion in purchasing power parity (PPP) values for more than 110 countries having significant R&D investments (more than USD 100 million). Thus, increased research and R&D investments in the life sciences industry are augmenting the growth of the market.

    Scope of the Report:

  • As per the , the term recombinant proteins are encoded by recombinant DNA, which involves insertion of DNA, encoding that particular protein into bacterial or mammalian cells. The protein is then purified, after getting expressed in these cells. A recombinant protein is produced either by molecular cloning or through polymerase chain reaction (PCR).

    Reasons for Buying Recombinant Protein Market Report:

    • This report provides pin-point analysis for changing competitive dynamics
    • It provides a forward looking perspective on different factors driving or restraining market growth
    • It provides a five-year forecast assessed on the basis of how the market is predicted to grow
    • It helps in understanding the key product segments and their future
    • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
    • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

    For More Information or Query or Customization Before Buying, Visit at – https://www.industryresearch.co/enquiry/pre-order-enquiry/14099224

    Key Market Trends:

    The Drug Discovery Segment is Expected to Grow at the Fastest Rate, during the Forecast Period

    The basic research segment held a maximum share in 2018, owing to the increasing investment on research activities and the introduction of new protein therapeutics, which has significantly contributed in the growth and development of recombinant therapeutic antibodies and proteins market.
    The drug discovery segment is projected to show significant growth during the forecast period, owing to the strong demand for recombinant proteins in drug discovery. Furthermore, companies are also collaborating for drug discovery and development purposes. For instance, in 2017, Crown Bioscience (CBI) Inc. entered into a collaboration with Jiangsu Qyun Bio-Pharmaceutical Co. Ltd, to develop CTLA-4 antibody.

    North American Region Holds the Largest Market Share of the Market and is Believed to Follow the Same Trend over the Forecast Period

    North America is expected to lead the global recombinant protein market, owing to the increased expenditure in research. The United States is anticipated to witness the highest growth, owing to the largest concentration of world-class research universities and academic medical centers. The R&D spending of the United States is around 2.7% of its gross domestic product (GDP). In 2014, the United States was leading the R&D investments in biotechnology and, since then, the US biotechnology research and investment has been growing at a steady rate. Development of new products and collaboration activities of biotechnology companies are likely to boost the growth of the recombinant protein market.

    Recombinant Protein Market Report Provides Comprehensive Analysis of:

    • Functional market industry outline
    • Up and downstream industry examination
    • Channels and propositions believability
    • Market challenge by key players
    • Enhancement suggestions examination

    Purchase this Report (Price 4250 USD for single user license) – https://www.industryresearch.co/purchase/14099224

    Report Highlights:

    • Market Dynamics – Drivers, Restraints, and Opportunities
    • Market Segmentation – Types, Applications, Regions, and Technology
    • Market Trends
    • Competitive Landscape
    • SWOT Analysis and Porter’s Five Forces Analysis

    Detailed TOC of Recombinant Protein Market Report 2019-2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Increasing Expenditure in Research and Development
    4.2.2 Growing Prevalence of Chronic Diseases
    4.2.3 Rising Inclination toward Biologics and Biosimilars
    4.2.4 Advanced Recombinant Products
    4.3 Market Restraints
    4.3.1 Expensive and Time-consuming Production Process
    4.3.2 Safety Issues
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 By Type of Product
    5.1.1 Hormone
    5.1.2 Growth Factor
    5.1.3 Cytokine
    5.1.4 Antibody
    5.1.5 Enzyme
    5.1.6 Other Type of Products
    5.2 By Application
    5.2.1 Basic Research
    5.2.2 Therapeutic Use
    5.2.3 Drug Discovery
    5.2.4 Biotechnology Industry
    5.2.5 Other Applications
    5.3 Geography
    5.3.1 North America
    5.3.1.1 US
    5.3.1.2 Canada
    5.3.1.3 Mexico
    5.3.2 Europe
    5.3.2.1 Germany
    5.3.2.2 UK
    5.3.2.3 France
    5.3.2.4 Italy
    5.3.2.5 Spain
    5.3.2.6 Rest of Europe
    5.3.3 Asia-Pacific
    5.3.3.1 China
    5.3.3.2 Japan
    5.3.3.3 India
    5.3.3.4 Australia
    5.3.3.5 South Korea
    5.3.3.6 Rest of Asia-Pacific
    5.3.4 Middle East and Africa
    5.3.4.1 GCC
    5.3.4.2 South Africa
    5.3.4.3 Rest of Middle East and Africa
    5.3.5 South America
    5.3.5.1 Brazil
    5.3.5.2 Argentina
    5.3.5.3 Rest of South America

    6 COMPETITIVE LANDSCAPE
    6.1 Company Profiles
    6.1.1 Abcam PLC
    6.1.2 Abnova Corporation
    6.1.3 Eli Lilly and Company
    6.1.4 Enzo Life Sciences Inc.
    6.1.5 Eurogentec (Kaneka Corporation)
    6.1.6 Merck KGaA
    6.1.7 Novo Nordisk AS
    6.1.8 ProSpec-Tany TechnoGene Ltd
    6.1.9 ProSpec-Tany TechnoGene Ltd
    6.1.10 F. Hoffmann-La Roche AG
    6.1.11 Thermo Fisher Scientific Inc.

    7 MARKET OPPORTUNITIES AND FUTURE TRENDS

     

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Hypnotics Market 2019 Industry Business Challenges, Share, Geographical Segmentation, Consumption Status and Opportunity Analysis: World Market Outlook to 2024

    Sodium Sulfide Industry 2019 Global Market Growth, Trends, Revenue, Key Suppliers, Demands and Detailed Insights on Upcoming Trends 2024

    File Basket Market 2019 | Global Industry Demand, Top Leading Countries by Size, Share, Future Growth Rate, and Investment by Forecast to 2023

    Cable Glands Market 2018 Global Industry Growth Analysis, Segmentation, Size, Share, Trend, Future Demand and Leading Players Updates by Forecast to 2023

  • Be First to Comment

    Leave a Reply

    Your email address will not be published. Required fields are marked *